Structural Basis for the Activation of Phenylalanine in the Non-Ribosomal Biosynthesis of Gramicidin S

Total Page:16

File Type:pdf, Size:1020Kb

Structural Basis for the Activation of Phenylalanine in the Non-Ribosomal Biosynthesis of Gramicidin S The EMBO Journal Vol.16 No.14 pp.4174–4183, 1997 Structural basis for the activation of phenylalanine in the non-ribosomal biosynthesis of gramicidin S Elena Conti1,2, Torsten Stachelhaus3, the peptide product. Each amino acid is activated by Mohamed A.Marahiel3 and Peter Brick1,4 adenylation of its carboxylate group with ATP and then transferred to the thiol group of an enzyme-bound phospho- 1Biophysics Section, Blackett Laboratory, Imperial College, pantetheine cofactor for possible modification and the 3 London SW7 2BZ, UK and Biochemie/Fachbereich Chemie, elongation reaction (Stachelhaus and Marahiel, 1995a; Philipps-Universita¨t Marburg, D-35032 Marburg, Germany Kleinkauf and von Do¨hren, 1996). 2 Present address: Laboratory of Molecular Biophysics, The cloning and sequencing of several peptide synthe- Rockefeller University, New York, NY10021, USA tase genes have revealed a conserved and ordered modular 4Corresponding author organization. Each module encodes a functional building unit containing ~1000 amino acids, which specifically The non-ribosomal synthesis of the cyclic peptide recognizes a single amino acid. Within such a protein antibiotic gramicidin S is accomplished by two large template-directed peptide biosynthesis, the occurrence and multifunctional enzymes, the peptide synthetases 1 and specific order of the modules in the genomic DNA dictate 2. The enzyme complex contains five conserved subunits the number and sequence of the amino acids to be of ~60 kDa which carry out ATP-dependent activation incorporated into the resulting oligopeptide. The modular of specific amino acids and share extensive regions of arrangement of peptide synthetases closely parallels the sequence similarity with adenylating enzymes such multienzyme complexes responsible for the biogenesis of as firefly luciferases and acyl-CoA ligases. We have fatty acids and of the polyketide family of natural products. determined the crystal structure of the N-terminal Furthermore, peptide synthetases, fatty-acid synthetases adenylation subunit in a complex with AMP and and polyketide synthetases all use enzyme-bound phospho- L-phenylalanine to 1.9 Å resolution. The 556 amino pantetheine cofactors as acyl carriers, in a thiotemplate acid residue fragment is folded into two domains with mechanism first proposed by Lipmann more than 20 the active site situated at their interface. Each domain years ago (Lipmann, 1971) and revised recently (Stein of the enzyme has a similar topology to the correspond- et al., 1996). ing domain of unliganded firefly luciferase, but a In particular, the synthesis of the cyclic antibiotic remarkable relative domain rotation of 94° occurs. gramicidin S has been studied in detail. Gramicidin S is This conformation places the absolutely conserved produced by the Gram-positive bacterium Bacillus brevis Lys517 in a position to form electrostatic interactions and consists of two identical pentapeptides joined head with both ligands. The AMP is bound with the phos- to tail. It is synthesized by the multienzyme complex phate moiety interacting with Lys517 and the hydroxyl gramicidin S synthetase, which is encoded by the 19 kb groups of the ribose forming hydrogen bonds with grs operon that includes the genes grsA, grsB and grsT. Asp413. The phenylalanine substrate binds in a hydro- The grsT gene, which is located at the 59-end of the grs phobic pocket with the carboxylate group interacting operon, encodes a 29 kDa protein homologous to fatty- with Lys517 and the a-amino group with Asp235. The acid thioesterases. The grsA gene product, gramicidin S structure reveals the role of the invariant residues synthetase 1 (GrsA) is a protein composed of 1098 amino within the superfamily of adenylate-forming enzymes acids (Hori et al., 1989; Kra¨tzschmar et al., 1989). and indicates a conserved mechanism of nucleotide GrsA activates L-phenylalanine to the corresponding acyl- binding and substrate activation. adenylate and catalyses the inversion of configuration of Keywords: non-ribosomal peptide biosynthesis/peptide the amino acid. D-phenylalanine is then transferred to the synthetases/X-ray crystallography grsB gene product, gramicidin S synthetase 2 (GrsB), a 510 kDa polypeptide chain which sequentially activates proline, valine, ornithine and leucine and forms the peptide bonds in the elongation reaction, releasing the decapeptide Introduction (D-Phe-Pro-Val-Orn-Leu)2 after cyclization. A number of oligopeptides, some of which have important Each of the five modules in which the grs operon is medical and biotechnological applications, are produced organized encodes for highly conserved functional sub- by fungi and bacteria via a non-ribosomal mechanism. units. The major one is a 60 kDa fragment which recog- Peptides such as the cyclic gramicidin S and cyclosporin nizes a specific amino acid and catalyses the adenylation A, the lactone actinomycin, the branched bacitracin and of the amino acid carboxylate group with the α-phosphate the linear precursor of both penicillin and cephalosporin, of ATP. This adenylation subunit is conserved not only are synthesized by large multifunctional enzymes which within all known peptide synthetases, but also shares act as protein templates for the growing polypeptide chain. extensive sequence similarity with firefly luciferases and Peptide synthetases catalyse the repetitive activation and acyl CoA ligases. Common to all these enzymes is the condensation of the constituent amino acids to yield ATP-dependent activation of substrates as acyl adenylates. 4174 © Oxford University Press X-ray structure of gramicidin synthetase 1 On the other hand, the adenylation subunit shares no sequence homology with enzymes involved in the ribo- somal synthesis of polypeptides, despite the fact that the formation of aminoacyl-adenylates is chemically ana- logous in the two systems. Indeed, the crystal structure of firefly luciferase has indicated a structural framework unrelated to those of both class I and class II aminoacyl- tRNA synthetases (Conti et al., 1996). We report here the crystal structure of the phenylalanine- activating subunit of gramicidin synthetase 1 (PheA) in a ternary complex with phenylalanine and AMP. The struc- ture reveals the role of residues which are highly conserved in the superfamily of adenylate-forming enzymes. In addition, the presence of the substrate provides details of the amino acid specificity and allows a sequence-based comparison to be made with other peptide synthetases. A comparison of the structure with that of unliganded firefly luciferase reveals that both a domain rotation and a conformational change of a loop in the N-terminal domain must occur for luciferase to form an active complex with luciferin and ATP. Fig. 1. Ribbon diagram of the PheA molecule with the large N-terminal domain shown in blue and the small C-terminal domain in green. The disordered loop (residues 192–196) near the active site is coloured violet. The AMP (red) and phenylalanine (orange) ligands are Results and discussion drawn using a space-filling representation. The side chain of Lys517 on the loop that projects down from the C-terminal domain is drawn Crystal structure determination in green using a ball-and-stick representation. The crystal structure of PheA was determined by the multiple isomorphous replacement method, together with B6 in sheet B while strands A5–A6 correspond to strands real-space non-crystallographic symmetry averaging and B1–B2. refined against 1.9 Å resolution diffraction data to a The C-terminal domain (residues 429–530) includes crystallographic R-factor and R-free (Bru¨nger, 1992) of two helices which pack against one side of a three- 21.4% and 24.6% respectively. The model for 512 residues stranded antiparallel β-sheet E as well as an additional has good stereochemistry and includes phenylalanine and small sheet containing two β-strands. The polypeptide AMP bound at the active site. No interpretable electron chain at the C-terminus of the protein loops back towards density is present for the 16 N-terminal residues, the 33 the N-terminal domain and then packs against the C-terminal residues, nor for a loop containing residues remaining face of β sheet E (Figure 1). Residues at both 192–196. The two copies of the molecule in the asymmetric the N- and C-termini of the polypeptide chain project out unit have a very similar conformation: after superposition from the surface of the molecule and are relatively less the r.m.s. difference in the position of the main chain well ordered. atoms of residues 21–530 is 0.26 Å. Ligand binding Description of the overall structure The crystal structure shows unambiguous electron density The polypeptide chain folds into two compact domains for the ligands bound at the active site (Figure 4). In spite (Figure 1). There are very few direct protein–protein of the presence of Mg-ATP and phenylalanine in the interdomain contacts and instead the interactions between crystallization conditions, the electron density is not con- the structural domains are mediated by a network of sistent with the product of the activation reaction: the hydrogen bonds between the side chains of the protein phenylalanyl adenylate has been hydrolysed to the corres- and a sandwiched layer of ordered water molecules. The ponding amino acid and AMP. Substrate recognition is much larger N-terminal domain comprising residues 17– accomplished by an extensive network of hydrogen bonds 428 contains three subdomains: a distorted β-barrel and with a number of charged or polar amino acid residues. two β-sheets which pack together to form a five-layered Most of the protein residues involved in substrate recogni- αβαβα tertiary structure (Figure 2). Subdomain A contains tion are contributed by the large N-terminal domain. a six-stranded β-sheet and three helices formed by a single However, it is a charged residue of the C-terminal domain, segment of the polypeptide chain (residues 91–203) while the strictly invariant Lys517, which is involved in two a seventh strand is formed by an insertion in the β-barrel key polar interactions with both the amino acid and the subdomain (Figure 3).
Recommended publications
  • Infant Antibiotic Exposure Search EMBASE 1. Exp Antibiotic Agent/ 2
    Infant Antibiotic Exposure Search EMBASE 1. exp antibiotic agent/ 2. (Acedapsone or Alamethicin or Amdinocillin or Amdinocillin Pivoxil or Amikacin or Aminosalicylic Acid or Amoxicillin or Amoxicillin-Potassium Clavulanate Combination or Amphotericin B or Ampicillin or Anisomycin or Antimycin A or Arsphenamine or Aurodox or Azithromycin or Azlocillin or Aztreonam or Bacitracin or Bacteriocins or Bambermycins or beta-Lactams or Bongkrekic Acid or Brefeldin A or Butirosin Sulfate or Calcimycin or Candicidin or Capreomycin or Carbenicillin or Carfecillin or Cefaclor or Cefadroxil or Cefamandole or Cefatrizine or Cefazolin or Cefixime or Cefmenoxime or Cefmetazole or Cefonicid or Cefoperazone or Cefotaxime or Cefotetan or Cefotiam or Cefoxitin or Cefsulodin or Ceftazidime or Ceftizoxime or Ceftriaxone or Cefuroxime or Cephacetrile or Cephalexin or Cephaloglycin or Cephaloridine or Cephalosporins or Cephalothin or Cephamycins or Cephapirin or Cephradine or Chloramphenicol or Chlortetracycline or Ciprofloxacin or Citrinin or Clarithromycin or Clavulanic Acid or Clavulanic Acids or clindamycin or Clofazimine or Cloxacillin or Colistin or Cyclacillin or Cycloserine or Dactinomycin or Dapsone or Daptomycin or Demeclocycline or Diarylquinolines or Dibekacin or Dicloxacillin or Dihydrostreptomycin Sulfate or Diketopiperazines or Distamycins or Doxycycline or Echinomycin or Edeine or Enoxacin or Enviomycin or Erythromycin or Erythromycin Estolate or Erythromycin Ethylsuccinate or Ethambutol or Ethionamide or Filipin or Floxacillin or Fluoroquinolones
    [Show full text]
  • Genes in Eyecare Geneseyedoc 3 W.M
    Genes in Eyecare geneseyedoc 3 W.M. Lyle and T.D. Williams 15 Mar 04 This information has been gathered from several sources; however, the principal source is V. A. McKusick’s Mendelian Inheritance in Man on CD-ROM. Baltimore, Johns Hopkins University Press, 1998. Other sources include McKusick’s, Mendelian Inheritance in Man. Catalogs of Human Genes and Genetic Disorders. Baltimore. Johns Hopkins University Press 1998 (12th edition). http://www.ncbi.nlm.nih.gov/Omim See also S.P.Daiger, L.S. Sullivan, and B.J.F. Rossiter Ret Net http://www.sph.uth.tmc.edu/Retnet disease.htm/. Also E.I. Traboulsi’s, Genetic Diseases of the Eye, New York, Oxford University Press, 1998. And Genetics in Primary Eyecare and Clinical Medicine by M.R. Seashore and R.S.Wappner, Appleton and Lange 1996. M. Ridley’s book Genome published in 2000 by Perennial provides additional information. Ridley estimates that we have 60,000 to 80,000 genes. See also R.M. Henig’s book The Monk in the Garden: The Lost and Found Genius of Gregor Mendel, published by Houghton Mifflin in 2001 which tells about the Father of Genetics. The 3rd edition of F. H. Roy’s book Ocular Syndromes and Systemic Diseases published by Lippincott Williams & Wilkins in 2002 facilitates differential diagnosis. Additional information is provided in D. Pavan-Langston’s Manual of Ocular Diagnosis and Therapy (5th edition) published by Lippincott Williams & Wilkins in 2002. M.A. Foote wrote Basic Human Genetics for Medical Writers in the AMWA Journal 2002;17:7-17. A compilation such as this might suggest that one gene = one disease.
    [Show full text]
  • Multiplex De Novo Sequencing of Peptide Antibiotics
    JOURNAL OF COMPUTATIONAL BIOLOGY Volume 18, Number 11, 2011 Research Articles # Mary Ann Liebert, Inc. Pp. 1371–1381 DOI: 10.1089/cmb.2011.0158 Multiplex De Novo Sequencing of Peptide Antibiotics HOSEIN MOHIMANI,1 WEI-TING LIU,2 YU-LIANG YANG,3 SUSANA P. GAUDEˆ NCIO,4 WILLIAM FENICAL,4 PIETER C. DORRESTEIN,2,3 and PAVEL A. PEVZNER5 ABSTRACT Proliferation of drug-resistant diseases raises the challenge of searching for new, more efficient antibiotics. Currently, some of the most effective antibiotics (i.e., Vancomycin and Daptomycin) are cyclic peptides produced by non-ribosomal biosynthetic pathways. The isolation and sequencing of cyclic peptide antibiotics, unlike the same activity with linear peptides, is time-consuming and error-prone. The dominant technique for sequencing cyclic peptides is nuclear magnetic resonance (NMR)–based and requires large amounts (milli- grams) of purified materials that, for most compounds, are not possible to obtain. Given these facts, there is a need for new tools to sequence cyclic non-ribosomal peptides (NRPs) using picograms of material. Since nearly all cyclic NRPs are produced along with related analogs, we develop a mass spectrometry approach for sequencing all related peptides at once (in contrast to the existing approach that analyzes individual peptides). Our results suggest that instead of attempting to isolate and NMR-sequence the most abundant com- pound, one should acquire spectra of many related compounds and sequence all of them simultaneously using tandem mass spectrometry. We illustrate applications of this approach by sequencing new variants of cyclic peptide antibiotics from Bacillus brevis, as well as sequencing a previously unknown family of cyclic NRPs produced by marine bacteria.
    [Show full text]
  • Teleomorph Hypocrea Jecorina)
    Downloaded from orbit.dtu.dk on: Dec 20, 2017 Unraveling the Secondary Metabolism of the Biotechnological Important Filamentous Fungus Trichoderma reesei ( Teleomorph Hypocrea jecorina) Jørgensen, Mikael Skaanning; Larsen, Thomas Ostenfeld; Mortensen, Uffe Hasbro; Aubert, Dominique Publication date: 2013 Document Version Publisher's PDF, also known as Version of record Link back to DTU Orbit Citation (APA): Jørgensen, M. S., Larsen, T. O., Mortensen, U. H., & Aubert, D. (2013). Unraveling the Secondary Metabolism of the Biotechnological Important Filamentous Fungus Trichoderma reesei ( Teleomorph Hypocrea jecorina). Kgs. Lyngby: Technical University of Denmark (DTU). General rights Copyright and moral rights for the publications made accessible in the public portal are retained by the authors and/or other copyright owners and it is a condition of accessing publications that users recognise and abide by the legal requirements associated with these rights. • Users may download and print one copy of any publication from the public portal for the purpose of private study or research. • You may not further distribute the material or use it for any profit-making activity or commercial gain • You may freely distribute the URL identifying the publication in the public portal If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Unraveling the Secondary Metabolism of the Biotechnological Important Filamentous Fungus Trichoderma reesei (Teleomorph Hypocrea jecorina) MJ-T-030 Mikael Skaanning Jørgensen Ph.D. Thesis November 2012 MJ-T-020 MJ-T-032 28 8 20 27 5 28 1 30 17 8 24 25 9 25 31 13 15 26 16 4 24 12 32 18 11 3 14 13 19 10 5 7 2 9 2521 22 23 Unraveling the Secondary Metabolism of the Biotechnological Important Filamentous Fungus Trichoderma reesei (Teleomorph Hypocrea jecorina) Mikael Skaanning Jørgensen Ph.D.
    [Show full text]
  • Adenylation Enzyme Characterization Using Γ -18O4-ATP
    View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Elsevier - Publisher Connector Chemistry & Biology Brief Communication Adenylation Enzyme Characterization 18 Using g - O4-ATP Pyrophosphate Exchange Vanessa V. Phelan,1 Yu Du,1 John A. McLean,1 and Brian O. Bachmann1,* 1Department of Chemistry, Vanderbilt University, Nashville, TN 37204, USA *Correspondence: [email protected] DOI 10.1016/j.chembiol.2009.04.007 SUMMARY ceuticals including penicillin, vancomycin, and rapamycin, to name a few (Fischbach and Walsh, 2006; Sieber and Marahiel, We present here a rapid, highly sensitive nonradioac- 2005). tive assay for adenylation enzyme selectivity determi- The biochemical assay of decoupled synthetases poses prac- nation and characterization. This method measures tical challenges because most adenylation reactions are not the isotopic back exchange of unlabeled pyrophos- formally catalytic. Isolated synthetases perform half-reactions 18 (Figure 1B) for subsequent amino acid (thio)esterification that phate into g- O4-labeled ATP via matrix-assisted laser desorption/ionization time-of-flight mass spec- are nearly stoichiometric with regard to their respective tRNA/T domains and aminoacyl adenylates are tightly bound enzyme trometry (MS), electrospray ionization liquid chroma- intermediates. Conventionally, adenylation enzyme selectivity tography MS, or electrospray ionization liquid chro- has been assayed using the ATP-32PPi (pyrophosphate) isotope matography-tandem MS and is demonstrated for exchange assay. In this method, the synthetase is incubated with both nonribosomal (TycA, ValA) and ribosomal excess 32PPi, amino acid, and ATP, and the reversible back synthetases (TrpRS, LysRS) of known specificity. exchange of labeled 32PPi into ATP is monitored by solid-phase This low-volume (6 ml) method detects as little as capture of ATP on activated charcoal followed by scintillation 0.01% (600 fmol) exchange, comparable in sensitivity counting.
    [Show full text]
  • E3 Appendix 1 (Part 1 of 2): Search Strategy Used in MEDLINE
    This single copy is for your personal, non-commercial use only. For permission to reprint multiple copies or to order presentation-ready copies for distribution, contact CJHP at [email protected] Appendix 1 (part 1 of 2): Search strategy used in MEDLINE # Searches 1 exp *anti-bacterial agents/ or (antimicrobial* or antibacterial* or antibiotic* or antiinfective* or anti-microbial* or anti-bacterial* or anti-biotic* or anti- infective* or “ß-lactam*” or b-Lactam* or beta-Lactam* or ampicillin* or carbapenem* or cephalosporin* or clindamycin or erythromycin or fluconazole* or methicillin or multidrug or multi-drug or penicillin* or tetracycline* or vancomycin).kf,kw,ti. or (antimicrobial or antibacterial or antiinfective or anti-microbial or anti-bacterial or anti-infective or “ß-lactam*” or b-Lactam* or beta-Lactam* or ampicillin* or carbapenem* or cephalosporin* or c lindamycin or erythromycin or fluconazole* or methicillin or multidrug or multi-drug or penicillin* or tetracycline* or vancomycin).ab. /freq=2 2 alamethicin/ or amdinocillin/ or amdinocillin pivoxil/ or amikacin/ or amoxicillin/ or amphotericin b/ or ampicillin/ or anisomycin/ or antimycin a/ or aurodox/ or azithromycin/ or azlocillin/ or aztreonam/ or bacitracin/ or bacteriocins/ or bambermycins/ or bongkrekic acid/ or brefeldin a/ or butirosin sulfate/ or calcimycin/ or candicidin/ or capreomycin/ or carbenicillin/ or carfecillin/ or cefaclor/ or cefadroxil/ or cefamandole/ or cefatrizine/ or cefazolin/ or cefixime/ or cefmenoxime/ or cefmetazole/ or cefonicid/ or cefoperazone/
    [Show full text]
  • The Inducers 1,3-Diaminopropane and Spermidine Cause The
    JOURNAL OF PROTEOMICS 85 (2013) 129– 159 Available online at www.sciencedirect.com www.elsevier.com/locate/jprot The inducers 1,3-diaminopropane and spermidine cause the reprogramming of metabolism in Penicillium chrysogenum, leading to multiple vesicles and penicillin overproduction Carlos García-Estradaa,⁎, Carlos Barreiroa, Mohammad-Saeid Jamia, Jorge Martín-Gonzáleza, Juan-Francisco Martínb,⁎⁎ aINBIOTEC, Instituto de Biotecnología de León, Avda. Real no. 1, Parque Científico de León, 24006 León, Spain bÁrea de Microbiología, Departamento de Biología Molecular, Universidad de León, Campus de Vegazana s/n; 24071 León, Spain ARTICLE INFO ABSTRACT Article history: In this article we studied the differential protein abundance of Penicillium chrysogenum in Received 21 February 2013 response to either 1,3-diaminopropane (1,3-DAP) or spermidine, which behave as inducers Accepted 15 April 2013 of the penicillin production process. Proteins were resolved in 2-DE gels and identified by Available online 30 April 2013 tandem MS spectrometry. Both inducers produced largely identical changes in the proteome, suggesting that they may be interconverted and act by the same mechanism. Keywords: The addition of either 1,3-DAP or spermidine led to the overrepresentation of the last 1,3-diaminopropane enzyme of the penicillin pathway, isopenicillin N acyltransferase (IAT). A modified form of Spermidine the IAT protein was newly detected in the polyamine-supplemented cultures. Both Penicillin inducers produced a rearrangement of the proteome resulting in an overrepresentation of Penicillium chrysogenum enzymes involved in the biosynthesis of valine and other precursors (e.g. coenzyme A) of Vesicles penicillin. Interestingly, two enzymes of the homogentisate pathway involved in the degradation of phenylacetic acid (a well-known precursor of benzylpenicillin) were reduced following the addition of either of these two inducers, allowing an increase of the phenylacetic acid availability.
    [Show full text]
  • | Hao Wanathi Movie Plena Matuma Wa Mt
    |HAO WANATHI MOVIEUS009943500B2 PLENA MATUMA WA MT (12 ) United States Patent ( 10 ) Patent No. : US 9 ,943 , 500 B2 Page (45 ) Date of Patent: Apr . 17 , 2018 ( 54 ) METHODS OF TREATING TOPICAL A61K 9 /0046 ; A61K 9 / 06 ; A61K 47 /10 ; MICROBIAL INFECTIONS A61K 47 / 14 ; A61K 47 / 44 ; A61K 9 /0048 ; A61K 47/ 06 ; A61L 15 / 46 ; A61L ( 71 ) Applicant: LUODA PHARMA PTY LIMITED , 2300 /404 ; A61L 26 /0066 Caringbah ( AU ) See application file for complete search history . (72 ) Inventor : Stephen Page , Newtown ( AU ) ( 56 ) References Cited (73 ) Assignee : Luoda Pharma Pty Ltd , Caringbah U . S . PATENT DOCUMENTS (AU ) 3 ,873 , 693 A 3 / 1975 Meyers et al . 3 , 920 ,847 A * 11/ 1975 Chalaust .. .. A61K 9 /0014 Subject to any disclaimer, the term of this 514 / 512 ( * ) Notice : 4 ,772 , 470 A * 9 / 1988 Inoue .. .. .. .. .. A61K 9 / 006 patent is extended or adjusted under 35 424 / 435 U . S . C . 154 ( b ) by 0 days . 2005/ 0187199 Al * 8 /2005 Peyman .. .. .. A61K 8 / 36 514 / 154 ( 21) Appl. No .: 14 / 766 , 232 FOREIGN PATENT DOCUMENTS ( 22 ) PCT Filed : FebD . 10 , 2014 EP 0294538 A2 12 / 1988 WO WO - 2003/ 088965 A1 10 / 2003 ( 86 ) PCT No . : PCT/ AU2014 /000101 WO WO - 2006 /081327 A2 8 /2006 $ 371 ( c ) ( 1 ) , WO WO - 2008 /075207 A2 6 / 2008 ( 2 ) Date : Aug. 6 , 2015 OTHER PUBLICATIONS (87 ) PCT Pub . No .: W02014 / 121342 Weese et. al. , Veterinary Microbiology , 2010 , Elsevier, vol. 140 , pp . PCT Pub . Date : Aug . 14 , 2014 418 - 429 . * Brindle , Encyclopedia of Chemical Technology . Polyether antibi otics, Nov . 2013 , Wiley , Abstract and pp .
    [Show full text]
  • By Nicole M. Gaudelli
    MECHANISTIC AND STRUCTURAL STUDIES OF THE THIOESTERASE DOMAIN IN THE TERMINATION MODULE OF THE NOCARDICIN NRPS By Nicole M. Gaudelli A dissertation submitted to The Johns Hopkins University in conformity with the requirements for the degree of Doctor of Philosophy Baltimore, MD 2013 © Nicole M. Gaudelli 2013 All Rights Reserved Abstract The nocardicins are monocyclic -lactam antibiotics produced by the actinomycete Nocardia uniformis subsp., tsuyamanensis ATCC 21806. In 2004 the gene cluster responsible for the biosynthesis of the flagship antibiotic, nocardicin A, was identified. This gene cluster accommodates a pair of non- ribosomal peptide synthetase (NRPS) whose five modules are indispensible for antibiotic production. In accordance with the prevailing co-linearity model of NRPS function, a linear L,L,D,L,L pentapeptide was predicted to be synthesized. Contrary to expectation and precedent, however, a stereodefined series of synthesized potential peptide substrates for the nocardicin thioesterase (NocTE) domain failed to undergo hydrolysis. The stringent discrimination against peptide intermediates was dramatically overcome by prior monocyclic -lactam formation at an L-seryl site to render now facile substrates for C-terminal epimerization and hydrolytic release. It was concluded through biochemical and kinetic experimentation that the TE domain acts as a gatekeeper to hold the assembling peptide on an upstream domain until -lactam formation takes place and then rapidly catalyzes epimerization and hydrolysis to discharge a fully-fledged pentapeptide -lactam harboring nocardicin G, the simplest member of the nocardicin family. An x-ray crystal structure of the TE domain revealed a catalytic center containing the expected Asp, His, Ser triad. Mutational analysis of these catalytic residues along with a proximal His established that the His of the catalytic triad was likely responsible for the epimerization activity rendered by the domain.
    [Show full text]
  • Complete Thesis
    University of Groningen Nonribosomal peptide synthetases Zwahlen, Reto Daniel IMPORTANT NOTE: You are advised to consult the publisher's version (publisher's PDF) if you wish to cite from it. Please check the document version below. Document Version Publisher's PDF, also known as Version of record Publication date: 2018 Link to publication in University of Groningen/UMCG research database Citation for published version (APA): Zwahlen, R. D. (2018). Nonribosomal peptide synthetases: Engineering, characterization and biotechnological potential. University of Groningen. Copyright Other than for strictly personal use, it is not permitted to download or to forward/distribute the text or part of it without the consent of the author(s) and/or copyright holder(s), unless the work is under an open content license (like Creative Commons). The publication may also be distributed here under the terms of Article 25fa of the Dutch Copyright Act, indicated by the “Taverne” license. More information can be found on the University of Groningen website: https://www.rug.nl/library/open-access/self-archiving-pure/taverne- amendment. Take-down policy If you believe that this document breaches copyright please contact us providing details, and we will remove access to the work immediately and investigate your claim. Downloaded from the University of Groningen/UMCG research database (Pure): http://www.rug.nl/research/portal. For technical reasons the number of authors shown on this cover page is limited to 10 maximum. Download date: 04-10-2021 Nonribosomal peptide synthetases: Engineering, characterization and biotechnological potential Academic Thesis, University of Groningen, the Netherlands ISBN: 978-94-034-0674-9 978-94-034-0673-2 (e-book) Printing: Eikon + Cover: Reto D.
    [Show full text]
  • Antimicrobial Resistance in Bacteria
    Cent. Eur. J. Med. • 4(2) • 2009 • 141-155 DOI: 10.2478/s11536-008-0088-9 Central European Journal of Medicine Antimicrobial resistance in bacteria Review Article Katrijn Bockstael*, Arthur Van Aerschot** Laboratory for Medicinal Chemistry, Rega Institute for Medical Research, Katholieke Universiteit Leuven, 3000 Leuven, Belgium Received 9 July 2008; Accepted 17 November 2008 Abstract: The development of antimicrobial resistance by bacteria is inevitable and is considered as a major problem in the treatment of bacterial infections in the hospital and in the community. Despite efforts to develop new therapeutics that interact with new targets, resistance has been reported even to these agents. In this review, an overview is given of the many therapeutic possibilities that exist for treatment of bacterial infections and how bacteria become resistant to these therapeutics. Keywords: Antimicrobial agents • Resistance development • Efflux • Alteration of drug target • Antibacterials © Versita Warsaw and Springer-Verlag Berlin Heidelberg. 1. Introduction 2. Different mechanisms of resistance to antimicrobials The history of humankind can be regarded from a medical point of view as a struggle against infectious 2.1. Intrinsic resistance diseases. Infections were the leading cause of death Bacteria may be inherently resistant to an antimicrobial. th worldwide at the beginning of the 20 century. Since This passive resistance is a consequence of general the discovery of penicillin by Alexander Fleming in adaptive processes that are not necessary linked to a 1929 and the first introduction of the sulpha drugs by given class of antimicrobials. An example of natural Domagk in 1932, the number of new antimicrobials resistance is Pseudomonas aeruginosa, whose low available has increased tremendously between 1940 membrane permeability is likely to be a main reason for and 1960.
    [Show full text]
  • Towards Combinatorial Biosynthesis of Pyrrolamide Antibiotics in Streptomyces Celine Aubry
    Towards combinatorial biosynthesis of pyrrolamide antibiotics in Streptomyces Celine Aubry To cite this version: Celine Aubry. Towards combinatorial biosynthesis of pyrrolamide antibiotics in Streptomyces. Bio- chemistry [q-bio.BM]. Université Paris Saclay (COmUE), 2019. English. NNT : 2019SACLS245. tel-02955510 HAL Id: tel-02955510 https://tel.archives-ouvertes.fr/tel-02955510 Submitted on 2 Oct 2020 HAL is a multi-disciplinary open access L’archive ouverte pluridisciplinaire HAL, est archive for the deposit and dissemination of sci- destinée au dépôt et à la diffusion de documents entific research documents, whether they are pub- scientifiques de niveau recherche, publiés ou non, lished or not. The documents may come from émanant des établissements d’enseignement et de teaching and research institutions in France or recherche français ou étrangers, des laboratoires abroad, or from public or private research centers. publics ou privés. Towards combinatorial biosynthesis of pyrrolamide antibiotics in Streptomyces Thèse de doctorat de l'Université Paris-Saclay préparée à l’Université Paris-Sud École doctorale n°577 Structure et Dynamique des Systèmes Vivants (SDSV) Spécialité de doctorat : Sciences de la vie et de la Santé Thèse présentée et soutenue à Orsay, le 30/09/19, par Céline AUBRY Composition du Jury : Matthieu Jules Professeur, Agroparistech (MICALIS) Président du Jury Yanyan Li Chargée de recherche, MNHN (MCAM) Rapportrice Stéphane Cociancich Chercheur, CIRAD (BGPI) Rapporteur Annick Méjean Professeure, Université Paris-Diderot (LIED) Examinatrice Hasna Boubakri Maitre de conférences, Université Claude Bernard Lyon I (Ecologie microbienne) Examinatrice Sylvie Lautru Chargée de recherche, CNRS (I2BC) Directrice de thèse Acknowledgements J’ai insisté pour rédiger l’ensemble de ma thèse en anglais.
    [Show full text]